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Most renal cell carcinomas (RCC) show only simple chromosomal changes. However, a more complex cytogenetic pattern has been
found in a subgroup of aggressive RCC, indicating that further accumulation of chromosome changes could play a role in tumour
progression. To explore the possible mechanisms behind cytogenetic evolution in RCC, a parallel assessment of chromosome
mutations and mitotic segregation pattern in eight tumours was performed. In the majority of cases, no abnormalities in the cell
division machinery were found and the rate of alterations in chromosome copy number, as measured by interphase FISH, was similar
to that in non-neoplastic cells. This was reflected by relatively simple karyotypes, with little cytogenetic intratumour heterogeneity. In
contrast, another group of tumours exhibited several cytogenetically related clones with additional structural chromosomal changes
at two or more ploidy levels and a frequency of copy number alterations that was higher than in normal cells. In these cases, the
telomere repeat sequences were abnormally short and chromosomal breakage–fusion–bridge events were observed at cell division,
as well as multipolar configurations and supernumerary centrosomes. Abnormalities of the cell division machinery may thus
contribute to the evolution of complex karyotypes and genetic intratumour heterogeneity in a subgroup of RCC.
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Renal cell carcinomas (RCC) typically exhibit relatively simple
chromosome changes, and a strong correlation has been
established between the cytogenetic abnormalities and the
histopathological classification (Kovacs et al, 1997). Unbalanced
structural rearrangements, leading to deletions in the short arm of
chromosome 3, are common in nonpapillary (clear cell) RCC, but
are rare in papillary tumours. Papillary RCC, on the other hand,
often exhibit polysomies for chromosomes 7, 12 and 17, and loss of
the Y chromosome. Little evidence of genetic intratumour
heterogeneity has been presented in RCC: of the 818 published
and cytogenetically investigated cases of renal adenocarcinoma,
only 193 cases (24%) showed more than one clone, and only 71
cases (9%) had more than two clones (Mitelman et al, 2003). This
is in sharp contrast to the scenario in many other epithelial
malignancies, which often exhibit highly complex cytogenetic
patterns. Furthermore, the TP53 protein, which is believed to be an
important safeguard against DNA damage and is inactivated in the
majority of human cancers, is only inactivated in approximately
20% of RCC (Contractor et al, 1997). Nonetheless, TP53 mutation
as well as aneuploidy have been suggested to predict poor survival
among these patients (Ljungberg et al, 1996; Girgin et al, 1999),
indicating that some tumours may acquire a more aggressive
phenotype through the disruption of cell cycle checkpoints and
subsequent cytogenetic evolution.
One mechanism that may induce complex chromosome
rearrangements is telomere shortening. When the number of
TTAGGG repeats at the chromosome ends reaches a certain critical
level, the protective telomeric DNA–protein complex is disrupted
(de Lange, 2002). The exposure of free double-stranded DNA then
leads to the formation of unstable ring and dicentric chromo-
somes, which may trigger cytogenetic rearrangements through
breakage–fusion–bridge (BFB) events (McClintock, 1940; Gissels-
son et al, 2001). In RCC, measurements of terminal restriction
fragment lengths have demonstrated that 70% of the tumours have
shorter telomeres than normal renal epithelial cells (Dahse et al,
1999), and a correlation has been observed between pronounced
telomere shortening and chromosomal end fusions (Holzman et al,
1993). However, whether these processes actually lead to an
increased rate of chromosome mutation in RCC has not been
assessed. In the present study, telomere status was evaluated in
eight RCC and compared to the pattern of cytogenetic changes, the
occurrence of cell division abnormalities and the histopathological
classification.
MATERIAL AND METHODS
Cell culture and chromosome banding
Eight RCC were selected for analysis from a series of consecutive
cases based on the finding of an abnormal karyotype: karyotypi-
cally normal cases and cases showing only non-clonal aberrations
were excluded from the study, whereas all cases with clonal
changes were included (Table 1). Tumour biopsies were minced
with scissors and disaggregated overnight in 180Uml
 1 collage-
nase II (Cooper Biomedical, Lakewood, NJ, USA). The resulting
cell suspension was frozen in culture medium with 10% DMSO,
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sand stored in liquid nitrogen until further analysis. After thawing,
cells were cultured on chamber slides or in culture flasks in RPMI
1640 medium with HEPES buffer, supplemented with 17% foetal
bovine serum, 1IUml
 1 insulin, 1ngml
 1 epidermal growth
factor, 0.23mgml
 1 L-glutamine, 100IUml
 1 penicillin and
0.2mgml
 1 streptomycin. After a first harvest and chromosome
banding analysis, the remaining cultures were propagated until
90% confluence was reached (3–5 days) and then subcultured
once or twice before further analyses. Harvest and chromosome
banding with Wright’s stain were according to standard methods
(Mandahl, 2001).
Interphase analysis
Interphase fluorescence in situ hybridisation (FISH) analysis was
performed using commercially available probes for the centro-
meric alphoid DNA of chromosomes 3, 7, 12, 13 and 17. Stringency
washing was in 1  SSC at 721C for 2min and probe detection was
according to standard procedures. To assess the degree of
variation in chromosome copy number, the proportion of cells
with copy numbers outside the modal number was evaluated
(Lengauer et al, 1997); in cases where karyotypically normal cells
were also present in the cultures, the disomic cells were included in
the stem line. At least 250 nuclei were analysed for each
hybridisation. As controls, karyotypically normal peripheral blood
lymphocytes stimulated by phytohaemagglutinin were used. As it
could not be excluded that copy-number alterations not present in
vivo were acquired during prolonged tissue culturing, normal
dermal fibroblasts, cultured for four population doublings, were
included as an additional reference.
Analysis of telomeric repeat sequences
Previous studies have shown that a subset of chromosomes with
abnormally short or absent telomeric TTAGGG repeats is a more
common source of genomic instability in tumours, than overall
telomere shortening (Artandi et al, 2000; Gisselsson et al, 2001). To
detect critically short telomeres in individual chromosomes,
TTAGGG repeats were visualised by FISH with fluorescein-
conjugated (CCCTAA)3 peptide nucleic acid probes (Landsdorp
et al, 1996). Signal intensity was directly quantified by the
Cytovision software (Applied Imaging, Newcastle, UK) and the
number of negative chromosome termini for each metaphase cell
was scored. At least 20 cells were evaluated in each case. This
method does not constitute a precise measurement of telomere
length, nor does the absence of signal exclude the presence of a low
number of remaining TTAGGG repeats. Nonetheless, previous
studies have demonstrated that the method yields a valid
assessment of the protective capacity of individual telomeres
(Gisselsson et al, 2001).
Analysis of mitotic cell morphology
For analysis of mitotic figures, cells on chamber slides were briefly
washed in phosphate-buffered saline (PBS), fixed in methanol:a-
cetic acid (3:1) at  201C for 30min, air-dried, and stained with
haematoxylin and eosin. At least 30 anaphase and 100 metaphase
cells were analysed in each case.
Centrosome detection
Cells on chamber slides were washed in PBS for 5min, fixed in
methanol at  201C for 30min and air-dried. Centrosomes were
then detected as previously described (Gisselsson et al, 2002),
using murine monoclonal anti-g-tubulin antibodies (GTU-88,
Sigma, St. Louis, MS), biotinylated anti-mouse antibodies (E0354,
DAKO A/S, Denmark) and streptavidin-Alexa 594 (Molecular
Probes, Leiden, the Netherlands). As background, b-tubulin was
detected by murine monoclonal antibodies (2-28-33, Sigma),
followed by anti-mouse antibodies coupled to fluorescein iso-
thiocyanate (F0232, DAKO A/S). In each case, at least 50 cells were
evaluated regarding the number and structure of centrosomes. In
control fibroblasts, enlarged centrosomes, that is, those containing
42 centrioles, were found in approximately 2% of the cells,
whereas no cells with 42 centrosomes were found.
RESULTS
Chromosome banding analysis of cells from primary cultures
revealed only relatively simple karyotypes in cases 1–5, whereas
cases 6 and 7 showed complex cytogenetic patterns (Table 1). In
case 8, two different biopsies from the tumour parenchyma were
analysed separately, of which one (A) showed cells with only
Table 1 Clinical data and karyotypes
Case Age/Sex
a Histological type Grade T-stage Karyotype
1 51/F Clear cell I pT2 45,XX,del(3)(p12),der(13;14)(q10;q10) [15]
2 64/F Clear cell I pT2 45,XX, 3,der(7)t(3;7)(q11;q11),der(19)t(7;19)(q11;q13) [21]/46,XX [22]
3 82/F Clear cell I pT1 42,XX,der(2)t(2;3)(p25;q11), 3, 4,+5,del(11)(p13), 14,der(17)t(17;18)(p11;q11),
 18, 19 [5]/46,XX [9]
4 58/F Clear cell II pT3c 47,XX,+3 [cp3]/47–48,X, X,+3,+17,+r [cp3]/47–49,XX,+17 [2]/47,XX,
+7 [cp5]/47,XX,+18 [cp3]/48,XX,+X [cp2]/46,XX [25]
5 79/M Clear cell II pT2N1 47–48,X, Y,+5,+8,+12,+16,+der(?17)del(17)(p13)del(17)(q23), 18, 20 [cp12]
6 70/M Clear cell II pT1 43,X, Y,t(1;17)(p36;q21),der(1)t(1;17)(p36;q21),+5,der(?7)t(3;7)(q21;p22),
 14, 15,der(15)t(5;15)(q11;p11), dic(16;?)(p13;?), 18 [cp28]/42–43,
idem,add(14)(q32), der(15)t(5;15),+15[cp4]/43,idem,add(14)(q32) [2]/43,
idem,dic(14;?)(q32;?)[cp6]/43–44,idem,+r [cp3]/80–86,idemx2 [cp7]/84–86,idemx2,dic(14;?)x2 [cp3]
7 66/M Clear cell II pT3a 44–46,X, Y,der(1)t(1;1)(p35;q12),+3,der(3)del(3)(p12p21)del(3)(p25)x2, 6,+7,
add(11)(q21), 14, 19, 22,+r, +mar [cp20]/43,X, Y,del(1)(p34),der(3)
del(3)del(3),+7, 9,add(11), 14 [cp4]/44,X, Y,der(3)del(3)del(3), 6,+7, i(8)(q10),t(10;19)(q22;q13),
 14 [cp4]/68–71,XX, Y,+3,der(3)del(3)del(3)x2, 6,+7,+7, 8,+12, 13, 14,der(14)
t(4;14)(q12;p11),der(14)t(8;14)(q11;p11),+16, 18,+20,+21,+22 [cp18]/83–91,idemx2 [cp13]
8A 39/M Papillary II pT3a 48–49,X, Y,+7,+7,+12,+17 [25]
8B 48–49,X, Y,+7,+7,+12,+17 [cp59]/49,idem,der(19)t(3;19)(q13;q13) [cp25]/48,idem, 8,
der(15)t(8;15)(q11;p11), der(19)t(3;19) [cp3]/97–98,idemx2,add(19)(q13)x2 [cp3]/46,XY
aF¼female; M¼male.
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snumerical changes, whereas the other (B) exhibited additional
structural aberrations. Of the tumours with simple karyotypes, 1–
3, 5 and 8A were monoclonal. Tumour 4 exhibited intratumour
variability with regard to numerical aberrations and a ring
chromosome, with three related and three unrelated clones. The
three cases with complex karyotypes (6, 7 and 8B) all exhibited
several related clones with variability in both structural and
numerical aberrations (Figure 1).
To assess the intratumour heterogeneity of numerical chromo-
some aberrations also in the non-dividing cell population,
interphase FISH with centromeric probes for five different
chromosomes was performed on cells from six of the tumours
(Figure 2A; Table 2), cultured for approximately four generations
(passage 2). All cultures were initiated from approximately the
same number of cells. The cases with simple karyotypes (1, 4, 5 and
8A) showed an elevated proportion of cells (43%) with copy
numbers outside the modal number compared to peripheral blood
lymphocytes. However, compared to normal dermal fibroblasts
cultured for an equal number of generations as the RCC cells, the
proportion of cells outside the modal number was either lower or
similar. On the other hand, the two cases with complex karyotypes
(6 and 7) exhibited rates two and three times higher than the
fibroblasts, respectively. The fibroblasts exhibited a normal 46,XY
karyotype at both generation 1 and generation 4, although
nonclonal changes were present.
When FISH analysis with probes for terminal TTAGGG repeats
was performed on all cases, the tumours with simple karyotypes
(1–5, and 8A) showed a hybridisation pattern similar to normal
lymphocytes and fibroblasts, with a maximum of two chromosome
ends below the detection level. The tumours with complex
karyotypes (6, 7 and 8B), on the other hand, exhibited a
subpopulation of cells with an elevated number of TTAGGG-
negative ends (Table 3; Figure 2B and C). In many of these cells,
nonclonal rings, dicentric chromosomes, or telomeric fusions
could be observed by DAPI staining (Figure 2D). Further scoring
of G-banded metaphase preparations showed that the tumours
with complex karyotypes exhibited these types of nonclonal
structural changes in 33–46% of cells (Figure 2E), whereas they
were not detected in the other cases, with the exception of a small
clonal ring chromosome in case 4. This ring showed little
structural variability among different cells, whereas the rings and
dicentrics in the complex karyotypes exhibited large intercellular
variability in structure and number. Analysis of cell division
morphology showed an abnormally high frequency of chromo-
some bridges (13–24%) compared to fibroblasts (o2%) only in
the complex cases (Figure 2F). These tumours also showed
multipolar mitoses in a small number of cells. In two of these
cases (6 and 7), immunofluorescence staining revealed an elevated
number of centrosomes (42) in approximately 10% of cells,
whereas all the other tumours and the fibroblasts showed only one
or two centrosomes (Figure 2G and H).
DISCUSSION
In contrast to the cytogenetic scenario observed in many other
epithelial malignant tumours, evidence of clonal evolution has not
been presented in RCC (Mitelman et al, 2003). Indeed, in this
study, four of the cases exhibited no cytogenetic intratumour
heterogeneity and one case showed variability limited to chromo-
some copy number. Taken together, these five tumours contained
many of the changes described as primary cytogenetic abnorm-
alities in RCC, including loss of 3p material and polysomies for
chromosomes 7, 12 and 17. Analysis of telomere status and mitotic
morphology did not show any abnormalities in these cases,
dicentric chromosomes were not found, and the ring chromosome
observed in one of the cases underwent no further evolution.
Interphase FISH analysis did not reveal a higher heterogeneity in
chromosome copy number compared to cultured fibroblasts,
indicating that the generation rate of numerical chromosome
changes was comparable to that in normal cells in vitro. This is
consistent with statistical analysis showing that the majority of
chromosomal changes in RCC most likely depend on rare and
mutually independent events (Ho ¨glund et al, 2001). The three
tumours with complex karyotypes (6, 7 and 8B) all exhibited
considerable cytogenetic intratumour variability with respect to
both structural and numerical changes. In addition, nonclonal
rings and dicentrics were common and interphase FISH indicated
considerable heterogeneity also regarding numerical changes. In
case 8, the two biopsies exhibited highly disparate levels of
cytogenetic complexity. All changes found in the simpler
karyotype of biopsy A were also seen in the karyotype of biopsy
B, indicating that clonal evolution had indeed occurred in a
subpopulation of the tumour cells. In all the three cases, signals for
telomeric repeats were absent from several chromosome termini,
and chromosome bridges were found at anaphase, indicating that
the cytogenetic evolution was associated with, if not dependent on,
BFB events.
BFB instability has been found in many solid tumours, including
osteosarcoma, pancreatic carcinoma (Gisselsson et al, 2001), soft
Figure 1 Representative karyotype of case 7, showing several structural
changes (arrows) and ring chromosomes (arrowhead; A); clonal evolution
of structural changes in tumour 8B illustrated by the stem line karyotype
(top), identical to that of tumour 8A, the partial karyotypes of the diploid
side lines with der(15)t(8;15) (right) and der(19)t(3;19) (left), and the
hypertetraploid side line with add(19) (bottom; B).
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stissue sarcoma (Gisselsson et al, 2000) and head and neck tumours
(Saunders et al, 2000). In these neoplasms, evidence of BFB events
has been found in the majority of analysed tumours, most of which
have shown complex karyotypes. On the other hand, BFB
instability has also been found in a small number of borderline
malignant or benign lesions with few clonal changes, such as
desmoid tumour, pleomorphic adenoma of the salivary gland, and
atypical lipomatous tumours (Gisselsson et al, 2000, 2002). In the
present study, two of the three cases with BFB instability were
classified as clear cell and one as papillary carcinoma at
histopathological examination. Two of the BFB-positive tumours
were locally invasive (pT3a), but also tumour 4 showed an invasive
phenotype (pT3c) and patient 5 had developed metastases at
diagnosis. Furthermore, the presence of BFB events in RCC showed
a correlation neither to patient age, nor to tumour size (data not
shown). Hence, BFB instability may occur in both of the main
histological classes of RCC and could also be associated with
locally aggressive behaviour. Several studies, including highly
sophisticated animal models, have suggested that neoplastic cell
populations with short telomeres are dependent on the activation
of telomerase in order to maintain telomere repeat length and
continuing tumour cell proliferation (Greider, 1996; Artandi and
DePinho, 2000; Rudolph et al, 2001). In tumours not expressing
telomerase, alternative lengthening of telomeres through recombi-
nation events such as telomere capture may play an equivalent role
(Meltzer et al, 1993). It is possible that the tumours with BFB
instability in the present study had lower levels of telomerase
activity compared to those with stable chromosome complements.
On the other hand, some studies of pancreatic carcinomas and
head and neck carcinomas have demonstrated that critically short
telomeres and BFB instability may occur also in the presence of
hTERT expression (Gisselsson et al, 2001, 2002), indicating that
telomerase expression does not completely protect chromosome
ends from recombination. Regrettably, quantification of telomer-
ase activity was not possible in the present study due to lack of
tumour material.
All the three cases with BFB instability exhibited multipolar cell
divisions. This is a common phenomenon in malignant tumours,
Figure 2 Interphase cell from case 6, showing multiple centromeric signals for chromosome 17 (A); normal telomeric signal pattern in case 8A (B),
compared to 8B (C), showing TTAGGG-negative chromosome ends (arrows); multiple chromosome ends and a ring chromosome (arrow) without
TTAGGG signals in case 7 (D); telomeric fusions (E), an anaphase bridge (F) and a tripolar cell division coordinated by three centrosomes (orange, G)i n
case 6; multiple centrosomes in a binucleated interphase cell in case 7 (H).
Table 2 Percentage of cells with chromosome copy numbers deviating
from the modal value
a
Case cen
b 3 cen 7 cen 12 cen 13 cen 17 Median
1 5 (2) 5 (2) 4 (2) 6 (2) 5 (2) 5
4 6 (2) 12 (2) 12 (2) 13 (2) 5 (2) 12
5 15 (2) 8 (2) 16 (3) 6 (2) 8 (2) 8
6 21 (2) 23 (2) 26 (2) 22 (2) 19 (2) 22
7 39 (2) 47 (2) 31 (2) 23 (2) 19 (2) 31
8A 2 (2) 26 (4) 2 (2) 1 (2) 8 (3) 2
Fibroblasts 8 (2) 12 (2) 10 (2) 10 (2) 6 (2) 10
Lymphocytes 1 (2) 5 (2) 1 (2) 2 (2) 2 (2) 2
aModal copy numbes are within parentheses;
bcentromeric alpha-satellite probe.
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swhich may be associated with abnormalities in the configuration of
centrosomes (Lingle et al, 1998, 2002). Indeed, increased numbers
of centrosomes were detected by immunofluorescence in two of
the RCC cases with multipolar mitoses. The mechanisms behind
the generation of supernumerary centrosomes are poorly under-
stood. The phenomenon has been associated with inactivation of
several tumour-suppressor proteins, and overexpression of genes
involved in cell cycle regulation, such as the human papilloma
virus genes E6 and E7 (Duensing et al, 2000) and the human
Aurora A gene (Zhou et al, 1998). It is possible that the same basic
defect in cell cycle regulation might lead simultaneously to BFB
instability and mitotic multipolarity. For instance, TP53 dysfunc-
tion has previously been associated with the accumulation of
supernumerary centrosomes (Carroll et al, 1999), and is also
known to facilitate the development of unbalanced translocations
and epithelial carcinomas through defective telomeres in a murine
model (Artandi et al, 2000). On the other hand, recent data from
an in vitro model system overexpressing Aurora A indicates that
the generation of supernumerary centrosomes could be dependent
on mitotic failure, leading to a duplication of the chromosome
complement as well as the number of centrosomes (Meraldi et al,
2002). One possible cause of such mitotic failure is anaphase
bridges, which may remain unbroken and thus mechanically
prevent cytokinesis (McClintock, 1938). In fact, both these
mechanisms could explain the positive, linear correlation between
the frequencies of anaphase bridges and multipolar mitoses
previously found in some genetically unstable tumours (Gisselsson
et al, 2002). Also, the present study lends support to an association
between BFB instability and mitotic multipolarity, as polyploidisa-
tion and multipolar cell divisions were restricted to the three RCC
cases showing anaphase bridges and telomere dysfunction.
Notably, one tumour (case 4) exhibited extensive cytogenetic
heterogeneity, but showed neither BFB events nor mitotic multi-
polarity. In contrast to the cases with complex karyotypes and
several related clones, this tumour had both related and unrelated
clones, with relatively few and mostly numerical changes. It is
possible that this cytogenetic pattern reflects an additional type of
chromosome instability, which is largely independent of gross
mitotic disturbances.
Taken together, our data suggest the presence of at least two,
possibly related modes of cytogenetic evolution in renal cell
carcinomas, one occurring through BFB events and the other
through multipolar cell division. Both these processes could evolve
secondary to a phase in which chromosome mutation is limited to
discrete structural and numerical changes, including those that
have been described as primary aberrations. When a tumour cell
population containing these early changes reaches a critically short
telomere length, a second wave of cytogenetic evolution might
ensue through mitotic multipolarity and BFB events, leading to
complex structural changes and shifts in ploidy level. Alternatively,
mitotic instability could occur synchronously to the primary
changes in a subgroup of tumours – possibly originating from
epithelial cells with unusually short telomeres. Irrespective of the
order of events, the molecular background of these largely
mechanical chromosomal processes should be an interesting target
for future analyses.
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